Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensitizing Potential of Abametapir Lotion in Healthy Volunteers
NCT02062073Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of abametapir in pediculosis capitis (4 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Sensitizing Potential of Abametapir Lotion at 8 weeks. Started Jan 2014; status: completed.
02
Drugs
abametapir
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT02062073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062073.